Table 1.

Clinical diagnosis and phenotypic features of ATLL cells

Patient designation	Diagnosis	WBC/mm3	CD3+, %	CD4+, %	CD8+, %	CD25+	CD7−/CD25+	CD7−	STAT binding activity
1	Acute ATL	77,000	100	97	0	98	97		None detected
2	Acute ATL	62,000	93	97	2	86	84		None detected
3	Acute ATL/TSP-HAM	35,000	94	93	2	96	88		STAT1/STAT3
4	Acute ATL	34,700	95	93	5	61		7	STAT5
5	Acute ATL	10,000	92	89	4	68		87	STAT5
6	Acute ATL	7,600	5	97	3	90		97	None detected
7	Acute ATL	13,800	92	95	3	83		92	STAT1/STAT3/STAT5
8	Chronic ATL	36,900	90	70	8	69		79	STAT3
9	Chronic ATL	17,900	94	90	5	85		84	None detected
10	Chronic ATL	6,000	83	70	14	63		73	STAT1/STAT3
11	ATLL	18,300	96	76	12	77	72		STAT3/STAT5
12	Acute ATL	19,000	94	92	2	93	89		STAT1/STAT3

WBC, white blood cell; TSP-HAM, tropical spastic paraparesis–HTLV-I-associated myelopathy.